Outcomes of androgenetic alopecia treated with dutasteride mesotherapy: A case series.
作者信息
Nohria Ambika, Desai Deesha, Páez-García Maria Salomé, Lo Sicco Kristen I, Shapiro Jerry
机构信息
Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
出版信息
JAAD Case Rep. 2024 Oct 15;54:53-58. doi: 10.1016/j.jdcr.2024.09.024. eCollection 2024 Dec.
Abstract
摘要
相似文献
1
Outcomes of androgenetic alopecia treated with dutasteride mesotherapy: A case series.
JAAD Case Rep. 2024 Oct 15;54:53-58. doi: 10.1016/j.jdcr.2024.09.024. eCollection 2024 Dec.
2
RF-Mesotherapy With Dutasteride: A Future Alternative Treatment for Androgenetic Alopecia.
Actas Dermosifiliogr (Engl Ed). 2020 Jun;111(5):419-420. doi: 10.1016/j.ad.2018.10.030. Epub 2020 May 13.
3
Mesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice.
J Drugs Dermatol. 2022 Jul 1;21(7):742-747. doi: 10.36849/JDD.6610.
4
Two Cases of Paradoxical Nonscarring Alopecia after Mesotherapy with Dutasteride.
Skin Appendage Disord. 2022 Jan;8(1):46-48. doi: 10.1159/000518043. Epub 2021 Aug 18.
5
Intradermal Delivery of Alopecia Therapeutics: Current State and Future Prospects.
Dermatol Surg. 2023 Sep 1;49(9):851-854. doi: 10.1097/DSS.0000000000003866. Epub 2023 Jun 22.
6
Mesotherapy with dutasteride for androgenetic alopecia: a concise review of the literature.
Eur J Dermatol. 2023 Feb 1;33(1):72. doi: 10.1684/ejd.2023.4443.
7
Frontal edema due to mesotherapy for androgenetic alopecia: A case series.
Dermatol Ther. 2022 Feb;35(2):e15247. doi: 10.1111/dth.15247. Epub 2021 Dec 13.
8
Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review.
Dermatology. 2024;240(5-6):833-843. doi: 10.1159/000541395. Epub 2024 Sep 13.
9
[Female androgenetic alopecia, a survey of causes and therapeutic options].
Cas Lek Cesk. 2015;154(2):90-4.
10
Dutasteride in Androgenetic Alopecia: An Update.
Curr Clin Pharmacol. 2017;12(1):31-35. doi: 10.2174/1574884712666170310111125.
本文引用的文献
1
Androgenetic Alopecia: Therapy Update.
Drugs. 2023 Jun;83(8):701-715. doi: 10.1007/s40265-023-01880-x. Epub 2023 May 11.
2
Two Cases of Paradoxical Nonscarring Alopecia after Mesotherapy with Dutasteride.
Skin Appendage Disord. 2022 Jan;8(1):46-48. doi: 10.1159/000518043. Epub 2021 Aug 18.
3
Efficacy of Intralesional and Oral Dutasteride in the Treatment of Androgenetic Alopecia: A Systematic Review.
Skin Appendage Disord. 2020 Nov;6(6):338-345. doi: 10.1159/000510697. Epub 2020 Oct 9.
4
Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia.
Int J Trichology. 2017 Jul-Sep;9(3):143-145. doi: 10.4103/ijt.ijt_73_16.
5
Dutasteride in Androgenetic Alopecia: An Update.
Curr Clin Pharmacol. 2017;12(1):31-35. doi: 10.2174/1574884712666170310111125.
6
Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation.
J Eur Acad Dermatol Venereol. 2013 Jun;27(6):686-93. doi: 10.1111/j.1468-3083.2012.04535.x. Epub 2012 Apr 6.
7
Androgens and alopecia.
Mol Cell Endocrinol. 2002 Dec 30;198(1-2):89-95. doi: 10.1016/s0303-7207(02)00372-6.
Zotero 插件